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Abstract
Background: Currently, most laboratories identify yeasts routinely on the basis of morphology
and biochemical reactivity. This approach has quite often limited discriminatory power and may
require long incubation periods. Due to the increase of fungal infections and due to specific
antifungal resistence patterns for different species, accurate and rapid identification has become
more important. Several molecular techniques have been described for fast and reliable
identification of yeast isolates, but interlaboratory exchangeability of identification schemes of
molecular techniques has hardly been studied. Here, we compared amplified ITS2 fragment length
determination by an ABI Prism 310 (Applied Biosystems, Foster City, Ca.) capillary electrophoresis
system with that obtained by a CEQ8000 (Beckman Coulter, Fullerton, Ca.) capillary
electrophoresis system.
Results: Although ITS2 size estimations on both systems differed and separate libraries had to be
constructed for each system, both approaches had the same discriminatory power with regard to
the 44 reference strains, identical identifications were obtained for 39/ 40 clinical isolates in both
laboratories and strains from 51 samples were correctly identified using CEQ8000, when
compared to phenotypic identification.
Conclusion: Identification of yeasts with ITS2-PCR followed by fragment analysis can be carried
out on different capillary electrophoresis systems with comparable discriminatory power.
Background
The clinical importance of yeast infections has increased
during the last decades, not only because the number of
yeast infections has increased, but also because yeast
infections have become a frequent cause of morbidity and
mortality in immunocompromised patients [1]. Besides
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the higher frequency there is also an important change in
the spectrum of the species causing clinical infections.
Whereas Candida albicans has long been considered as the
clinically most important species of the genus, the occur-
rence and pathogenic importance of the non-albicans spe-
cies has been increasing steadily [2]. Because antifungal
susceptibility is differing between the species, rapid and
reliable identification of the clinical isolates can contrib-
ute to an efficient therapy of the patient [3]. The conven-
tional identification of yeast isolates depends on
biochemical properties such as assimilation and fermen-
tation reactions and morphology [4], features which are
not always stable, which are often not easy to interpret,
and which may be time-consuming [5]. Biochemical iden-
tification has been standardized and (semi-)automated
(e.g. Vitek-2) [6], but this approach equally suffers from
the limitations of phenotypic identification in general. As
a solution for those problems, several PCR-based meth-
ods have been described. Some of these approaches rely
on species-specific probes [7,8] – being limited to those
species for which probes are available, but most of them
are based on amplification using universal fungal primers,
followed by post-amplification analysis like probe
hybridization [9], sequencing [10,11], restriction analysis
[12,13], temperature gradient gel electrophoresis [14] or –
most simply and least laborious – fragment length deter-
mination [15-18]. In addition, fingerprinting techniques
primarily developed for strain typing are also used for
identification: RAPD [19] and AFLP [20,21]. Finally, tech-
niques like real-time PCR [22,23], pyrosequencing [24]
and Luminex flow cytometry [25] have been used for
identification of yeasts.
The principle of Internal Transcribed Spacer 2 (ITS2)-PCR
was initially described by Turenne et al. [13]. Amplifica-
tion of the ITS2-PCR is followed by capillary electrophore-
sis for the precise determination of the fragment length,
whereby the length of the fragment is used for identifica-
tion. Evaluation, adaptation and expansion of the
number of species included has been carried out at our
laboratory and has resulted in a publicly available data-
base, listing the ITS2-sizes for 39 yeast species [16]http://
allserv.ugent.be/~mvaneech/Yeasts.pdf. Subsequently, an
interlaboratory evaluation indicated that the ITS2-PCR
technique and the database could be exchanged between
different laboratories, when using the same electrophore-
sis platform, i.e. ABI310 (Applied Biosystems, Foster City,
Ca.) [17].
Our present aim was to evaluate the interlaboratory
exchangeability of the technique between laboratories
using different capillary electrophoresis systems, i.e.
ABI310 versus CEQ8000 (Beckman Coulter, Fullerton,
Ca.), for the size determination of the amplified ITS2-frag-
ments.
Results
Construction of an ITS2-length library using CEQ8000
Since ITS2-fragment length determination on CEQ8000
was expected to be different from that obtained on
ABI310, we determined the length of a set of 44 reference
strains, representing 33 species and subspecies, using the
CEQ8000 capillary electrophoresis apparatus. The
obtained lengths on CEQ8000 are listed in Table 1 (Addi-
tional file 1) and are compared with the lengths obtained
on ABI310, as reported earlier [16], and with the theoret-
ically expected lengths, as derived from published
sequences.
It could be observed that the values obtained on the
CEQ8000 were always higher than on ABI310. The size
differences were in the range of 0.3 basepairs (bp) for C.
neoformans subsp. gattii (strain IHEM 04170) to 7.2 bp for
Malassezia furfur (strain IHEM 03967), with an average of
2.61 bp (SD 1.31 bp). There was no correlation between
fragment size and size difference and there was no con-
stant size difference. As illustrated in Table 1 (Aditional
file 1), we could neither establish a correlation between
%GC-content of the ITS2-region and migration differ-
ences as observed on both machines.
The accuracy of fragment length calculation by CEQ8000
seemed to be somewhat higher than that achieved by
ABI310, since in 33 of 44 cases the calculated length on
CEQ8000 was closer to the theoretical length than that
calculated on ABI310 (Table 1, Additional file 1).
Although the absolute lengths obtained on CEQ8000 dif-
fered from those on ABI310, fragment length determina-
tion of the amplified ITS2 region on CEQ8000 enabled
discrimination between the same species that could be
differentiated on the ABI310. All species included could
be identified to species level, except for the members of
the genus Trichosporon, for which four of the five tested
species had the same ITS2-fragment length. Since none of
all other yeast species tested had an ITS2 of this length, the
Trichosporon species could be identified as a group.
Applicability
The obtained ITS2-fragment lengths for the different spe-
cies on CEQ8000 (Table 1, Additional file 1) were used as
reference values with which ITS2-lengths of unknowns
were compared.
ITS2-fragment length determination on the CEQ8000
enabled the identification of the yeasts present in the cul-
tures of 51 clinical samples, of which 5 samples contained
different yeast species simultaneously. The following spe-
cies and mixtures of species were identified: C. albicans (n
= 12), C. albicans + C. glabrata (1), C. albicans + C. parapsi-
losis (1), C. glabrata (11), C. guilliermondii (1), C. kefyr (1),
C. parapsilosis (12), C. tropicalis (7), C. tropicalis + C. albi-BMC Microbiology 2005, 5:14 http://www.biomedcentral.com/1471-2180/5/14
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cans (1), C. tropicalis + C. albicans + C. glabrata (1), C. trop-
icalis + C. glabrata (1), C. krusei (1), and Ustilago maydis
(1). No misidentifications occurred, compared to pheno-
typic identification.
Exchangeability of data
To evaluate the exchangeability of the technique between
two laboratories using a different capillary electrophoresis
apparatus, clinical strains were exchanged. Laboratory G
identified 20 clinical isolates from the Ghent University
Hospital on ABI310 and sent these to laboratory A, where
identification was carried out on CEQ8000. Laboratory A
identified the clinical isolates from 20 cultured samples
from the Onze Lieve Vrouw Ziekenhuis Aalst, using the
CEQ8000 and sent these to laboratory G, where identifi-
cation was carried out on ABI310. The results of this com-
parison are presented in Table 2 (Additional file 2). The
identification obtained with ITS2-PCR in both laborato-
ries was in agreement for 39 of the 40 cultures. One cul-
ture yielded another identification, respectively as C.
albicans using the CEQ8000 and as C. krusei by means of
the ABI310. Retesting at laboratory A indicated that the
sample contained a mixture of both species, while
repeated culture and retesting at laboratory G yielded
again only C. krusei.
Based on culture results, one sample (OLVA 5397) was
thought to contain a mixture of C. albicans and a non-albi-
cans isolate. Both ITS2-PCR identification systems
revealed that the mixture contained in fact three species,
namely C. albicans, C. tropicalis and C. glabrata.
During this study, one isolate was misidentified in both
laboratories using ITS2-PCR. An isolate identified bio-
chemically as C. dubliniensis, was identified as C. krusei by
means of ITS2-PCR in both laboratories. ITS2-sequencing,
whereby the obtained sequence was compared to all
known sequences in Genbank using BLAST, confirmed
the biochemical identification as C. dubliniensis. The ITS2-
sequence showed highest sequence similarity to C. dub-
liniensis, but contained a 2-bp indel (insertion/deletion)
compared to the ITS2 sequence of the C. dubliniensis refer-
ence strains that had been used to construct the ITS2-
length library. Genbank contains 17 ITS2 sequences of C.
dubliniensis, of which 6 have the 2-bp indel.
The ITS2 size library lists C. krusei as having a two bp
shorter ITS2 size than that of C. dubliniensis and this
explains the misidentification. This finding was added to
the library, cautioning that in some cases C. dubliniensis
strains with an aberrant ITS2 fragment length may occur
and thus may result in a misidentification as C. krusei.
Discussion and conclusions
ITS2-PCR followed by fragment length determination by
capillary electrophoresis on ABI310 (Applied Biosystems)
has been shown to be a fast and efficient identification
technique for clinically important yeast species [16,18]
and for which data are exchangeable between laboratories
using the same capillary electrophoresis system [17]. Here
we evaluated whether comparative discriminatory power
could be obtained on another capillary electrophoresis
apparatus, in casu on CEQ8000, and whether identifica-
tions obtained in different laboratories using different
capillary electrophoresis systems were identical.
Since the fragment length estimation differs between dif-
ferent capillary electrophoresis systems, it was found nec-
essary to recreate an ITS2 length library for the CEQ8000.
The different size estimation most probably results from
migration differences between different systems, caused
by the usage of different fluorescent labels on the primers
and of different polymers in the capillaries. Also the use of
different marker fragments may result in differences
between calculated lengths. It was observed that size esti-
mations on CEQ8000 were always higher than on
ABI310, ranging from 0.3 to 7.2 bp differences, without
any notable consistency in the observed differences.
However, differences were constant for each species, such
that a new library for CEQ8000 could be constructed. It
was found that the species that could be differentiated
from each other by ITS2 length determination on ABI310
could also be differentiated by using the CEQ8000.
ITS2-PCR was not very useful for differentiation between
species of the genus Trichosporon. Identification of Trichos-
poron  species was also impossible by ITS2-PCR on the
ABI310 [16], and even sequencing of the ITS2 region is
not always sufficient for final discrimination between all
the species [26]. A more reliable identification of Trichos-
poron spp. can be obtained by sequencing a more variable
region like IGS1 (intergenetic spacer region 1) [27] or
making use of species specific probes and detection of
hybridization in the Luminex flow cytometer [25].
During this study, both an additional problem and an
additional possiblity of ITS2 fragment length determina-
tion for the identification of yeast species was encoun-
tered.
Apparently, strains with aberrant ITS2 lengths occur. Here,
a strain of which the biochemical identification as C. dub-
liniensis was confirmed by ITS2-sequence determination
was misidentified by both laboratories as C. krusei, when
identification was based on ITS-length determination. It
could be shown that this was the result of a 2 bp indel of
the ITS2-region of this strain, an indel which is present inBMC Microbiology 2005, 5:14 http://www.biomedcentral.com/1471-2180/5/14
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6 of the 17 published C. dubliniensis sequences. Further
research is needed to find out whether the subdivision
that can be made on the basis of ITS2-length corresponds
to epidemiological or clinical relevance. An additional
advantage of ITS2-PCR was observed when a mixed cul-
ture was studied. In order to identify the separate species
present in mixed cultures, isolation of the cultures is nec-
essary when identification is based on biochemical fea-
tures or on sequencing of genes. However, when using
ITS2-PCR on either CEQ8000 or ABI310, the different
species present can be identified immediately, since one
will obtain an ITS2-fingerprint composed of several peaks,
each with a length corresponding to the respective species
present in the mixed sample.
Our results obtained on mixed culture samples indicate
that ITS2-PCR could be applied for direct, non culture
based, simultaneous detection of different species from a
clinical sample. Whether this will be possible, will only
depend on the strength of the DNA-extraction method
used.
Methods
Yeast strains
A set of 44 reference strains or well-documented strains
belonging to 33 species and subspecies, which were refer-
ence and type strains from culture collections or for which
the correct identification had been obtained by sequenc-
ing of the ITS2 region in previous studies [16,17], were
used as reference panel (Table 1, Additional file 1).
A series of 40 cultures on Sabouraud agar (Becton Dickin-
son, Erembodegem, Belgium) – 20 from each hospital –
of clinical samples with unknown yeast isolates was also
studied. Routine identification of these isolates was car-
ried out using Auxacolor (Sanofi-Pasteur, Marnes-la-
Coquette, France) at the Ghent University Hospital
(GUH) laboratory (Laboratory G) and using Chromagar
(Novolab, Geraardsbergen, Belgium) and API 32C
(bioMérieux, Marcy-l'Etoile, France) at the Onze Lieve
Vrouw Ziekenhuis Aalst (OLVA) laboratory (Laboratory
A).
The selection of 40 cultures contained 43 clinical isolates
belonging to the following species: C. albicans (n = 9), C.
dubliniensis (1), C. glabrata (5), C. guilliermondii (3), C.
kefyr (2), C. lusitaniae (1), C. parapsilosis (8), C. rugosa (1),
C. tropicalis (6), Debaryomyces hansenii (1), C. krusei (5)
and  Ustilago maydis (1). All 40 culture plates were
exchanged between laboratories, to study whether the
identifications obtained in one laboratory could be con-
firmed in the other.
DNA-extraction, PCR, capillary electrophoresis and 
analysis
a. DNA-extraction
Laboratory A
DNA was extracted by alkaline lysis. A loopful (1µl inocu-
lation needle) of yeast colonies was suspended in 40 µl of
0.05 M NaOH / 0.25 M SDS and incubated for 15 minutes
at 95°C, whereafter 500 µl milliQ water was added.
Laboratory G
DNA-extraction was carried out using a boilling-freezing
method. A loopful of yeast colonies was suspended in 250
µl TE-buffer, heated for 15 minutes at 95°C and immedi-
ately frozen at -70°C for at least 15 minutes.
b. PCR
Laboratory A
PCR reactions were carried out in 50 µl reactions contain-
ing 10 µl yeast DNA extract, 1 x PCR buffer (Invitrogen,
Carlsbad, Ca.), 0.2 mM of each dNTP, 1.5 mM MgCl2, 5 U
of Taq polymerase (Invitrogen) and 0.5 µM of primers
ITS4 TCCTCCGCTTATTGATATGC) and ITS86 (GTGAAT-
CATCGAATCTTTGAAC). Primer ITS86 was labeled with
Beckman dye D4 (Proligo, Boulder, Co.). The amplifica-
tion was carried out with the following protocol: 5 min at
94°C, 30 cycli of 1 min at 94°C, 1 min at 55°C and 1 min
at 72°C and a final extension of 7 min at 72°C, followed
by cooling at 4°C.
Laboratory G
PCR reactions were carried out in 25 µl reactions contain-
ing 2.5 µl yeast DNA extract, PCR Master Mix (Qiagen,
Hilden, Germany) and 0.5 µM of primers ITS4 and ITS86
(sequence see above). Primer ITS86 was HEX-labeled
(Applied Biosystems). The amplification was carried out
with the following protocol: 5 min at 94°C, 30 cycli of 1
min at 94°C, 1 min at 55°C and 1 min at 72°C and a final
extension of 7 min at 72°C, followed by cooling at 4°C.
c. Capillary electrophoresis
Laboratory A
Capillary electrophoresis was performed on the eight cap-
illary system CEQ8000. PCR products were diluted ten-
fold in nuclease-free water (Sigma, St. Louis, Mo.). Four µl
of the PCR dilution was combined with 40 µl of SLS load-
ing mix (deionized formamide, Analis, Namur, Belgium)
and 0.5 µl of the CEQ DNA Size standard kit-600 (Analis).
Samples were run on the CEQ8000 under the standard
method FRAG-4: capillary temperature of 50°C, denatur-
ing temperature of 90°C for 120 seconds, injection volt-
age of 2.0 kV for 30 seconds and separation voltage of 4.8
kV for 60 minutes. The total running time for one row of
eight samples was 85 minutes.BMC Microbiology 2005, 5:14 http://www.biomedcentral.com/1471-2180/5/14
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Laboratory G
The capillary electrophoresis apparatus used was the ABI
Prism 310 Genetic Analyser (Applied Biosystems, Foster
City, Ca.). Electrophoresis was done in a single capillary,
filled with liquid polymer (POP-4: Performance Opti-
mized Polymer, Applied Biosystems). One µl of the PCR-
product was added to the electrophoresis mixture (0.1 µl
HD 400 marker, 0.3 µl of the ROX-500 marker (both from
Applied Biosystem) and 12.1 µl of deionized formamide.
All samples were first denaturated (2 min 95°C) before
placement on the capillary. Injection of the sample was
carried out at 5 kV for 10 sec, followed by an electro-
phoreis at 60°C and 15 kV, during 35 min.
d. Size determination of the fragment length, followed by 
identification
At laboratory A, the size and identity of the amplified
ITS2-fragment was determined by the Fragment Analysis
Module of the CEQ8000. The specific parameters con-
cerning the marker standard used and the reference
library, containing the ITS2 fragment lengths of the refer-
ence strains needed for identification, have to be selected
by the user. The program then automatically calculates the
size of the amplified ITS2-fragment by means of the
known lengths of the fragments of the CEQ DNA Size
standard kit-600 (Analis). This calculated fragment length
is then compared to the ITS2 fragment lengths present in
the selected library and as a result, the Fragment Analysis
Module of the CEQ8000 gives an identification of the
unknown strain.
At laboratory G, the derivation of the fragment length is
carried out by the Gene Scan analysis software (Applied
Biosystems). The results were presented in a table indicat-
ing length and intensity of the observed fragments. The in-
house software BaseHopper [16] enables to compare the
obtained fragment length to those lengths present in the
ITS2-database.
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